Micromedic: Leading the Path to Introducing Novel Cancer Diagnostic Tools
Micromedic Technologies Ltd. is a public company traded on the Tel Aviv Stock Exchange (MCTC), focusing on the development and commercialization of cancer diagnostic products.
Micromedic forms a cluster that manages the development of a variety of products across the cancer diagnostic value chain. From screening and risk identification, through diagnostics, personalized medicine, and monitoring disease recurrence,
Micromedic identifies projects that fill unmet needs in various cancer related indications, and turns them into viable marketable products.
Micromedic operates through strategic collaborations and in-licensing from leading scientific institutes worldwide as well as in-house based research.
As of December 2011 the company's larger share holder, BioLight Life Sciences Investments (TASE: BOLT, OTCQX: BLGTY), realizes its clusters approach by forming the “Cancer Diagnostic Cluster”.